ResMed

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases.

CEO

Michael J. Farrell

CEOMichael J. Farrell

Employees

10,600

Employees10,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1989

Founded1989

Employees

10,600

Employees10,600

RMD Key Statistics

Market cap

40.19B

Market cap40.19B

Price-Earnings ratio

26.85

Price-Earnings ratio26.85

Dividend yield

0.83%

Dividend yield0.83%

Average volume

1.49M

Average volume1.49M

High today

$276.43

High today$276.43

Low today

$269.62

Low today$269.62

Open price

$271.78

Open price$271.78

Volume

1.42M

Volume1.42M

52 Week high

$293.81

52 Week high$293.81

52 Week low

$199.92

52 Week low$199.92

Stock Snapshot

With a market cap of 40.19B, ResMed(RMD) trades at $275.96. The stock has a price-to-earnings ratio of 26.85 and currently yields dividends of 83.2%.

During the trading session on 2026-02-09, ResMed(RMD) shares reached a daily high of $276.43 and a low of $269.62. At a current price of $275.96, the stock is +2.4% higher than the low and still -0.2% under the high.

Trading volume for ResMed(RMD) stock has reached 1.42M, versus its average volume of 1.49M.

The stock's 52-week range extends from a low of $199.92 to a high of $293.81.

RMD News

Simply Wall St 1d

ResMed Is Up 5.2% After Strong Quarter, Dividend Hike And Completed Buyback Program

In late January 2026, ResMed reported higher quarterly sales of US$1,422.81 million and net income of US$392.59 million, alongside declaring a US$0.60 per-share...

TipRanks 1d

ResMed Chairman Emeritus Peter Farrell Sells Shares Under 10b5-1 Plan

An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available. ResMed Chairman emeritus and directo...

Simply Wall St 3d

Why You Might Be Interested In ResMed Inc. For Its Upcoming Dividend

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see ResMed Inc. ( ) is about to trade ex-dividend in the n...

Analyst ratings

69%

of 29 ratings

Buy

69%

Hold

27.6%

Sell

3.4%

More RMD News

Simply Wall St 5d

ResMed Builds Digital Sleep Apnea Ecosystem As Investors Track Valuation

ResMed (NYSE:RMD) is expanding its digital health ecosystem around sleep apnea diagnosis and treatment, supported by tools such as myAir, AirView, and Brightree...

Simply Wall St 6d

ResMed At Wearable And AI Turning Point In Sleep Apnea Care

ResMed (NYSE:RMD) is at an inflection point as wearable devices move into mainstream use for sleep apnea screening. Recent FDA approvals support broader adopti...

Yahoo Finance 7d

Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge - Yahoo Finance

...

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.